Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Astellas study reveals kidney regeneration insights

Astellas study reveals kidney regeneration insights

21st June 2013

Astellas has reported findings from a study it carried out alongside Kyoto University that could aid future studies into kidney regenerative medicine.

The company conducted research alongside Kyoto University's Center for iPS Cell Research and Application, showing how one of the processes in which kidneys are regenerated from human-induced pluripotent stem cells and embryonic stem cells can be carried out more efficiently.

Their new method of differentiating nephron progenitor cells from the intermediate mesoderm – by treating it with various growth factors and chemical compounds – could make it easier in future to generate cells for use in the development of therapeutic medicines.

Creating new kidney regenerative medicines is considered important in order to contribute to the treatment of chronic renal failure and other refractory renal diseases, given the lack of therapy options for these conditions.

A statement from Astellas said: "Taking advantage of these new results, Astellas will aim to realise innovative cell therapies."

Earlier this week, it was announced that Astellas has joined the SAFE-BioPharma Association, an industry coalition dedicated to developing and implementing a new digital identity and signature standard.ADNFCR-8000103-ID-801602228-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.